CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial ...

Anika Therapeutics, Inc. (Nasdaq: ANIK), a global leader in osteoarthritis pain management and regenerative solutions, today announced topline results from its U.S. pivotal clinical trial of Hyalofast ...

Anika Therapeutics' (NASDAQ:ANIK) stock falls as the company's cartilage repair product Hyalofast misses key trial endpoints ...

Shares of Anika Therapeutics hit a 52-week low after it said its Hyalofast cartilage-repair product didn't meet its co-primary endpoints in a Phase III study. The stock was recently down 24% to $8.43 ...